An Open-Label, Single-Dose, Randomized, Four-Way Crossover Study In Healthy Volunteers To Evaluate The Effects Of Caloric Content And Time Of Dosing On The Pharmacokinetics Of Pregabalin Controlled Release Formulation As Compared To The Immediate Release Formulation.
Phase of Trial: Phase I
Latest Information Update: 31 Jul 2014
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Postherpetic neuralgia; Postoperative pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 13 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Feb 2011 New trial record